SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/01/2016
Entire Document
 

Table of Contents

          The following table presents our summary balance sheet data as of September 30, 2015:

    on an actual basis;

    on a pro forma basis to give effect to (i) the amendment and restatement of our license agreement with NCH in January 2016, which terminated NCH's right to sell shares of common stock that it owns back to us in certain circumstances, and (ii) the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 8,695,662 shares of common stock, which will occur automatically upon the closing of this offering; and

    on a pro forma as adjusted basis to give further effect to our issuance and sale of 4,250,000 shares of common stock in this offering at an assumed initial public offering price of $20.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and estimated offering expenses payable by us.

 
  As of September 30, 2015  
 
 
Actual
 
Pro Forma
 
Pro Forma as
Adjusted
 
 
   
  (in thousands)
   
 

Balance Sheet Data:

                   

Cash and cash equivalents

  $ 69,706   $ 69,706   $ 146,256  

Working capital

    63,301     63,301     139,851  

Total assets

    70,319     70,319     146,869  

Total liabilities

    6,519     6,519     6,519  

Redeemable common stock

    1,033          

Total preferred stock

    1          

Common stock

    1     2     2  

Additional paid-in capital

    108,155     109,188     185,738  

Accumulated deficit

    (45,390 )   (45,390 )   (45,390 )

Total stockholders' equity

    62,767     63,800     140,350  

          The pro forma information discussed above is illustrative only and will be adjusted based on the actual initial public offering price and other terms of our initial public offering determined at pricing. Each $1.00 increase (decrease) in the assumed initial public offering price of $20.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, working capital, total assets, additional paid-in capital and total liabilities, redeemable preferred stock and stockholders' equity by $4.0 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1.0 million shares in the number of shares offered by us at the assumed initial public offering price would increase (decrease) each of cash and cash equivalents, total assets, additional paid-in capital and total liabilities, redeemable preferred stock and stockholders' equity by $18.6 million.

10



© AveXis, Inc. All Rights Reserved.